Cargando…
Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice
Acute coronary syndrome is a factor for poor prognosis and recurrent cardiovascular events. Adequate antiplatelet therapy is crucial in patients with the acute coronary syndrome for risk reduction. Such treatment is well described in four documents issued by the European Society of Cardiology, which...
Autores principales: | Tubek, Stanisław, Kuliczkowski, Wiktor, Gąsior, Mariusz, Gierlotka, Marek, Kubica, Jacek, Budaj, Andrzej, Witkowski, Adam, Reczuch, Krzysztof, Ponikowski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356830/ https://www.ncbi.nlm.nih.gov/pubmed/34400916 http://dx.doi.org/10.5114/aic.2021.107492 |
Ejemplares similares
-
The effects of P2Y(12) adenosine receptors’ inhibitors on central and peripheral chemoreflexes
por: Tubek, Stanislaw, et al.
Publicado: (2023) -
Percutaneous occlusion of large aneurysmal right coronary artery saphenous vein bypass graft
por: Kuliczkowski, Wiktor, et al.
Publicado: (2021) -
Iatrogenic circumflex coronary artery injury after mitral valve replacement
por: Bulak, Luiza, et al.
Publicado: (2021) -
Bivalirudin use in acute coronary syndrome patients undergoing percutaneous coronary interventions in Poland: Clinical update from expert group of the Association on Cardiovascular Interventions of the Polish Cardiac Society
por: Kołtowski, Łukasz, et al.
Publicado: (2019) -
Andexanet alfa — Recommendations for clinical use. Multidisciplinary experts’ standpoint
por: Kubica, Jacek, et al.
Publicado: (2023)